Antiviral properties of glycyrrhizic acid and its semisynthetic derivatives

Mini-Reviews in Medicinal Chemistry

Volumn 9, Issue 8, 2009, Pages 996-1001

  Pompei, Raffaello ^a   Laconi, Samuela ^a   Ingianni, Angela ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Anti viral activity; Glycyrrhizic acid; Latent viral infection; Triterpene derivatives; Triterpenes

Indexed keywords

CARBENOXOLONE; CICLOXOLONE; GAMMA INTERFERON; GLYCYRRHETINIC ACID; GLYCYRRHIZIC ACID; GLYCYRRHIZIC ACID DERIVATIVE; NEOMINOPHAGEN C; PROSTAGLANDIN A1; SAPONIN; TRITERPENE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ALLERGY; ANTIVIRAL ACTIVITY; ARTICLE; CARCINOGENESIS; CELL STRAIN L 929; CELL TRANSFORMATION; CLINICAL TRIAL; CYTOKINE PRODUCTION; DRUG POTENTIATION; DRUG STRUCTURE; GLYCYRRHIZA GLABRA; GLYCYRRHIZA URALENSIS; HEPATITIS; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HERPES SIMPLEX VIRUS 1; HERPES VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATION; INFLUENZA VIRUS A; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; POLIOMYELITIS VIRUS 1; PROTEIN EXPRESSION; SARS CORONAVIRUS; VACCINIA VIRUS; VESICULAR STOMATITIS VIRUS; VIRUS HEPATITIS; VIRUS INHIBITION;

EID: 70349108834     PISSN: 13895575     EISSN: None     Source Type: Journal    
DOI: 10.2174/138955709788681636     Document Type: Article

References (37)

1. Taylor, R.F. Bacterial triterpenoids. Microbiol. Rev., 1984, 48, 181-98.
2. Guçlu-Ustundag, O.; Mazza, G. Saponins: properties, applications and processing. Crit. Rev. Food Sci. Nutr., 2007, 47, 231-58.
3. Asl, M.N.; Hosseinzadeh, H. Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds. Phytother. Res., 2008, 22, 709-24.
4. Dargan, D.J.; Subak-Sharpe, J.H. The effect of triterpenoid compounds on uninfected and herpes simplex virus-infected cells in culture. I. Effect on cell growth, virus particles and virus replication. J. Gen. Virol., 1985, 66, 1771-84.
5. Fujisawa, K.; Watanabe, Y.; Kimura, K. Terapeutic approach to chronic active hepatitis with glycyrrhizin. Asian Med. J., 1980, 23, 745-50.
6. Finney, R.S.H.; Somers, G.F. The anti-inflammatory activity of glycyrrhetinic acid and derivatives. J. Pharmacol., 1958, 10, 613-20.
7. Cherng, J.M.; Lin, H.J.; Hung, M.S.; Lin, Y.R.; Chan, M.H.; Lin, J.C. Inhibition of nuclear factor KappaB is associated with neuroprotective effects of glycyrrhizic acid on glutamate-induced excitotoxicity in primary neurons. Eur.J. Pharmacol., 2006, 547(1-3),10-21.
8. Pompei, R.; Flore, O.; Marcialis, M.A.; Pani, A.; Loddo, B. Glycyrrhizic acid inhibits virus growth and inactivates virus particles. Nature, 1979, 281 (5733), 689-90.
9. Pompei, R.; Pani, A.; Flore, O.; Marcialis, M.A.; Loddo, B. Antiviral activity of Glycyrrhizic acid. Experientia, 1980, 36, 304.
10. Pompei, R.; Marcialis, M.A. Effetto dell'acido glicirrizico sulla sintesi di glicoproteine del virus Herpes simplex tipo 1. Ig. Mod., 1985, 83, 385-91.
11. Lampis, G.; Ingianni, A.; Pompei, R. Synergistic effects of triterpenic compounds with prostaglandin A1 on Vaccinia virus infected L929 cells. Antiviral. Res., 1997, 36, 191-3.
12. Lampis, G.; Deidda, D.; Pinza, M.; Pompei, R. Enhancement of anti-herpetic activity of glycyrrhizic acid by physiological proteins. Antivir. Chem. Chemother., 2001, 12, 125-31.
13. Pompei, R.; Paghi, L.; Ingianni, A.; Uccheddu, P. Glycyrrhizic acid inhibits influenza virus growth in embryonated eggs. Microbiologica, 1983, 6, 247-50.
14. Fujisawa, Y.; Sakamoto, M.; Matsushita, M.; Fujita, T.; Nishioka, K. Glycyrrhizin inhibits the lytic pathway of complement - possible mechanism of its anti- inflammatory effect on liver cells in viral hepatitis. Microbiol. Immunol., 2000, 44(9), 799-804.
15. Sato, H.; Goto, W.; Yamamura, J.; Kurokawa, M.; Kageyama, S.; Takahara, T.; Watanabe, A., Shiraki, K. Therapeutic basis of glycyrrhizin on chronic hepatitis B. Antiviral Res., 1996, 30(2-3),171-7.
16. Crance, J.M.; Lévêque, F.; Biziagos, E. ; van Cuyck-Gandré, H. ; Jouan, A. ; Deloince, R. Studies on mechanism of action of glycyrrhizin against hepatitis A virus replication in vitro. Antiviral Res., 1994, 23(1),63-76.
17. De Clercq, E. Current lead natural products for the chemotherapy of human immunodeficiency virus (HIV) infection. Med. Res. Rev., 2000, 20(5), 323-49.
18. Abe, N.; Ebina, T.; Ishida, N. Interferon induction by glycyrrhizin and glycyrrhetinic acid in mice. Microbiol. Immunol., 1982, 26, 535-9.
19. Vapaatalo, H.; Linden, I-B.; Metsa-Ketela, T.; Kangasaho, M.; Laustiola, K. Effect of carbenoxolone on phosphodiesterases and prostaglandin synthetase activities. Experientia, 1978, 34, 384-5.
20. Mantovani, A.; Ricciardi, C.; Stazi, A.V.; Macri, C.; Piccioni, A.; Barellino, E.; De Vincenti, M.; Caiola, S.; Patriarca, M. Teratogenicity study of ammonium glycyrrhizinate in Sprague-Dawley rat. Food Chem. Toxicol., 1988, 26, 435-40.
21. Tolsticov, G.A.; Baltina, L.A.; Grankina, V.P.; Kondratenko, R.M. Licorice: biodiversity, chemistry and application in medicine, Academic Publishing House "Geo": Novosibirsk, 2007
22. Dargan, D.J.; Subak-Sharpe, J.H. The antiviral activity against herpes simplex virus of the triterpenoid compounds carbenoxolone sodium and cicloxolone sodium. J. Antimicrob. Chemother., 1986, 18 (Suppl. B), 185-200.
23. Dargan, D.J.; Subak-Sharpe, J.H. The effect of triterpenoid compounds on uninfected and herpes simplex virus-infected cells in culture. II. DNA and protein synthesis, polypeptide processing and transport. J. Gen. Virol., 1986, 67, 1831-50.
24. Dargan, D.J.; Aitken, J.D.; Subak-Sharpe, J.H. The effect of triterpenoid compounds on uninfected and herpes simplex virus-infected cells in culture. III. Ultrastructural study of virion maturation. J. Gen. Virol., 1988, 69, 439-44.
25. Dargan, D.J.; Subak-Sharpe, J.H. The difference in sensitivity to cicloxolone sodium between herpes simplex virus types 1 and 2 maps to the locations of genes UL22 (gH) and UL44 (gC). J. Gen. Virol., 1991, 72, 377-84.
26. Dargan, D.J.; Galt, C.B.; Subak-Sharpe, J.H. The effect of cicloxolone sodium on the replication of vesicular stomatitis virus in BSC-1 cells. J. Gen. Virol., 1992, 73, 397-406.
27. Dargan, D.J.; Galt, C.B.; Subak-Sharpe, J.H. The effect of cicloxolone sodium on the replication in cultured cells of adenovirus type 5, reovirus type 3, poliovirus type 1, two bunyaviruses and Semliki Forest virus. J. Gen. Virol., 1992, 73, 407-11.
28. Wan, B.Y.C.; Gottfried, S. Cytoprotective action of carbenoxolone sodium on ethanol-induced gastric lesions in rats and its inhibition by indomethacin. J. Pharm. Pharmacol., 1985, 37, 739-41.
29. Kondratenko, R.M.; Baltica, L.A.; Mustafina, S.R.; Vasileva, E.V.; Pompei, R.; Deidda, D.; Plyasunova, O.A.; Pokrovskii, A.G.; Tolsticov, G.A. The synthesis and antiviral activity of glycyrrhizic acid conjugates with alfa-D-Glucosamine and some glycosylamines. Russ. J. Bioorg. Chem., 2004, 30, 272-82.
30. Cinatl, J.; Morgenstern, B.; Bauer, G.; Chandra, P.; Rabenau, H.; Doerr, W. Glycyrrhizin, an active component of liquorice roots, inhibits the replication of SARS-associated coronavirus. Lancet, 2003, 361(9374), 2045-6.
31. Hoever, G.; Baltina, L.; Michaelis, M.; Kondratenko, R.; Tolsticov, G.A.; Doerr, H.W.; Cinatl, J.Jr. Antiviral activity of glycyrrhizic acid derivatives against SARS- Coronavirus. J. Med. Chem., 2005, 48, 1256-9.
32. Curreli, F.; Friedman-Kien, A.E.; Flore, O. Glycyrrhizic acid alters Kaposi sarcoma-associated herpesvirus latency, triggering p53-mediated apoptosis in transformed B lymphocytes. J. Clin. Invest., 2005, 115, 642-52.
33. Baltina, L.A. Chemical modification of glycyrrhizic acid as a route to new bioactive compounds for medicine. Curr. Med. Chem., 2003, 10, 155-71.
34. Lin, J.C. Mechanism of action of glycyrrhizic acid in inhibition of Epstein-Barr virus replication in vitro. Antiviral Res., 2003, 59, 41-7.
35. Lin, J.C.; Cherng, J.M.; Hung, M.S.; Baltina, L.A.; Baltina, L.; Kondratenko, R. Inhibitory effects of some derivatives of glycyrrhizic acid against Epstein-Barr virus infection: structure-activity relationships. Antiviral Res., 2008, 79(1), 6-11.
36. Numazaki, K.; Umetsu, M., Chiba, S. Effect of glycyrrhizin in children with liver dysfunction associated with cytomegalovirus infection. Tohoku J. Exp. Med., 1994, 172(2),147-53.
37. De Clercq, E.; Naesens, L.; De Bolle, L.; Schols, D.; Zhang, Y.; Neyts, J. Antiviral agents active against human herpesviruses HHV-6, HHV-7 and HHV-8. Rev. Med. Virol., 2001, 11(6), 381-95.